Company Update (NYSE:LLY): Lilly Announces Webcast to Discuss Ixekizumab Phase III Data

[PR Newswire] – INDIANAPOLIS, June 11, 2015 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) will host a webcast on June 23 to discuss three pivotal Phase III studies investigating ixekizumab for the . . . → Read More: Company Update (NYSE:LLY): Lilly Announces Webcast to Discuss Ixekizumab Phase III Data Similar Articles: Stock Update: Eli Lilly & Company (NYSE:LLY) – Lilly Declares Second-Quarter 2015 Dividend Stock Update (NYSE:LLY): Lilly to Participate in Bank of America Merrill Lynch Health Care Conference Market Update (NYSE:LLY): Lilly Confirms Date and Conference Call for First-Quarter 2015 Financial Results Announcement